查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771670

美国无菌连接器和焊接机市场规模、份额、趋势分析报告（按产品、应用、最终用途、细分市场预测，2025 年至 2033 年）

U.S. Aseptic Connectors And Welders Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

美国无菌连接器和焊接机市场的成长和趋势：

根据Grand View Research, Inc.的最新报告，预计到2033年，美国无菌连接器和焊接器市场规模将达到23.5亿美元，2025年至2033年的复合年增长率为14.8%。随着生物製药製造业对无菌封闭式系统解决方案的需求不断增长，该市场正经历强劲成长。一次性技术的兴起，加上生技药品、疫苗、细胞和基因疗法产品线的不断拓展，正在推动先进无菌流体处理系统的应用。製造商将污染预防、营运灵活性和法规合规性放在首位。

模组化和灵活生产设施的日益普及，进一步推动了市场发展，尤其是在合约研究组织 (CRO)、合约生产组织 (CMO) 和新兴生物技术公司中。随着缩短开发週期和降低污染风险的压力日益增大，各公司正在投资于能够适应不同批次规模和製程需求的坚固耐用、随时可用的无菌系统。

连接器设计、自动化管焊机以及与智慧製造平台整合的技术进步提高了生产效率，减少了人为错误，并支援即时製程监控。这些创新使无菌流体能够跨各种上游和下游处理步骤进行传输，从细胞培养和培养基製备到最终填充完成。随着无菌处理标准日益严格，对经过验证、符合 GMP 要求且可扩展的流体处理解决方案的需求正在重塑药物开发商和契约製造的筹资策略。

随着技术创新不断重塑生物製造，美国无菌连接器和焊接机市场有望在实现下一代无菌、高效且可扩展的药物製造方面发挥关键作用。随着策略伙伴关係关係、产品扩展和数位化整合的日益增长，该市场有望支持全球生物製药和先进疗法製造的未来成长。

美国无菌连接器和焊接机市场报告重点

  • 从产品来看，2024年，无菌连接器占据了美国无菌连接器和焊接器市场的主导地位。这种主导地位归因于其在一次性生物製程系统中的广泛应用，在这些系统中，保持无菌和封闭的流体路径至关重要。与传统方法相比，无菌连接器具有更高的灵活性、易用性并降低了污染风险，使其成为需要频繁更换和模组化系统配置的製程的理想选择。
  • 从应用角度来看，上游生物加工将在2024年以44.99%的市场份额引领市场，占据最大的收入份额。该领域占据主导地位，是因为在培养基製备、细胞培养和发酵过程中保持无菌至关重要。无菌连接器和焊接机支援每个阶段无菌液体的处理，最大限度地降低风险并确保稳定的产量。随着mRNA疗法、单株抗体和先进生技药品的兴起，上游生物加工将继续成为无菌技术投资和创新的重点。
  • 根据最终用途， OEM（目的地设备製造商）细分市场在2024年占据了最大的市场占有率，达到46.20%。 OEM已成为将无菌连接器和焊接器整合到经济高效的生物处理设备和一次性系统中的重要参与者，为生物製药製造商提供检验的即用型解决方案。 OEM与药品开发商和契约製造製造商建立了牢固的伙伴关係关係，这进一步巩固了OEM的主导地位，这些开发商和合约製造商依靠OEM提供预先配置的匹配系统来简化营运。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国无菌连接器和焊接机市场变数和趋势

  • 市场展望
    • 母市场展望
    • 相关/辅助市场展望。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 无菌连接器和焊接器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章美国无菌连接器和焊接机市场：产品评估和趋势分析

  • 产品细分仪表板
  • 美国无菌连接器和焊接器市场产品差异分析
  • 2021 年至 2033 年美国无菌连接器及焊接机市场规模及趋势分析（依产品）
  • 无菌连接器
    • 连接类型
    • 管尺寸
  • 无菌焊接机

第五章美国无菌连接器和焊接机市场：应用评估和趋势分析

  • 应用程式细分仪表板
  • 美国无菌连接器及焊接器市场应用趋势分析
  • 美国无菌连接器及焊接机市场规模及应用趋势分析（2021-2033）
    • 上游生物加工
    • 其他用途
    • 下游生物加工
    • 收穫和育肥

第六章美国无菌连接器和焊接机市场：最终用途估计和趋势分析

  • 最终用途细分仪表板
  • 美国无菌连接器和焊接器市场最终用途变化分析
  • 美国无菌连接器和焊接机市场规模及趋势分析（依最终用途），2021 年至 2033 年
  • 生物製药和製药公司
  • OEM
  • CRO 和 CMO
  • 学术研究所

第七章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Sartorius AG
    • Merck KGaA
    • Danaher Corporation（Cytiva）
    • Saint-Gobain
    • Dover Corporation（Colder Products Company）
    • Liquidyne Process Technologies, Inc.
    • MGA Technologies
    • Watson-Marlow Fluid Technology Solutions
    • Terumo BCT, Inc.
    • LePure Biotech LLC
Product Code: GVR-4-68040-629-4

U.S. Aseptic Connectors And Welders Market Growth & Trends:

The U.S. aseptic connectors and welders market size is projected to reach USD 2.35 billion by 2033, growing at a CAGR of 14.8% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is experiencing strong growth, driven by the increasing demand for sterile, closed-system solutions in biopharmaceutical manufacturing. The rise of single-use technologies, combined with the expanding pipeline of biologics, vaccines, cell, and gene therapies are fueling the adoption of advanced aseptic fluid handling systems. Manufacturers prioritize contamination control, operational flexibility, and regulatory compliance.

The growing adoption of modular, flexible manufacturing facilities further reinforces the market's momentum, especially among CROs, CMOs, and emerging biotech firms. With increasing pressure to shorten development timelines and reduce contamination risks, companies invest in robust, ready-to-deploy aseptic systems that adapt to different batch sizes and process needs.

Technological advancements in connector design, automated tube welders, and integration with smart manufacturing platforms improve production efficiency, reduce human error, and support real-time process monitoring. These innovations enable sterile fluid transfer across various upstream and downstream processing stages, from cell culture and media preparation to final fill-finish. As aseptic processing standards tighten, the need for validated, GMP-compliant, and scalable fluid handling solutions reshape procurement strategies among drug developers and contract manufacturers.

As innovation continues to reshape the biomanufacturing landscape, the U.S. aseptic connectors and welders market is poised to play a critical role in enabling the next generation of sterile, efficient, and scalable drug production. With strategic partnerships, product expansion, and digital integration on the rise, the market is well-positioned to support future growth in global biopharma and advanced therapeutic production.

U.S. Aseptic Connectors And Welders Market Report Highlights:

  • By product, aseptic connectors dominated the U.S. aseptic connectors and welders market in 2024. This dominance is attributed to their widespread use in single-use bioprocessing systems, where maintaining sterile, closed fluid pathways is critical. Aseptic connectors offer greater flexibility, ease of use, and reduced risk of contamination compared to traditional methods, making them ideal for processes that require frequent changeovers or modular system configurations.
  • By application, upstream bioprocessing led the market with a share of 44.99% in 2024, accounting for the largest revenue share. This segment's dominance is driven by the critical need to maintain sterility during media preparation, cell culture, and fermentation processes, where contamination can compromise entire production runs. Aseptic connectors and welders support sterile fluid handling at each stage, minimizing risk and ensuring consistent yields. With the rise of mRNA therapies, monoclonal antibodies, and advanced biologics, upstream bioprocessing remains a primary focus for investment and innovation in aseptic technologies.
  • By end use, OEMs (Original Equipment Manufacturers) segment held the largest market share of 46.20% in 2024. OEMs integrate aseptic connectors and welders into cost-effective bioprocessing equipment and single-use systems, making them essential players in delivering validated, ready-to-use solutions to biopharmaceutical manufacturers. Their dominance is reinforced by strong partnerships with drug developers and contract manufacturers, who rely on OEMs for pre-configured, compliant systems that streamline operations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Aseptic Connectors and Welders Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Expansion of Vaccine and Therapeutic Production
      • 3.2.1.2. Rise in the Adoption of Single-Use Technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Manufacturing Costs
      • 3.2.2.2. Regulatory Compliance
  • 3.3. Aseptic Connectors and Welders Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Aseptic Connectors and Welders Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Aseptic Connectors and Welders Market Product Movement Analysis
  • 4.3. U.S. Aseptic Connectors and Welders Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Aseptic Connectors
    • 4.4.1. Aseptic Connectors market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Connection type
      • 4.4.2.1. Connection type market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.2.2. Barbed fittings
      • 4.4.2.3. Barbed fittings market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.2.4. Luer locks
      • 4.4.2.5. Luer locks market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.2.6. Genderless
      • 4.4.2.7. Genderless market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.2.8. Others
      • 4.4.2.9. Others market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Tubing Size
      • 4.4.3.1. Tubing Size market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.3.2. 1/16 Inch
      • 4.4.3.3. 1/16 Inch-triphosphate market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.3.4. 1/4 Inch
      • 4.4.3.5. 1/4 Inch market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.3.6. 3/8 Inch
      • 4.4.3.7. 3/8 Inch market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.3.8. Others
      • 4.4.3.9. Others market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Aseptic Welders
    • 4.5.1. Aseptic Welders market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. U.S. Aseptic Connectors and Welders Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Aseptic Connectors and Welders Market Application Movement Analysis
  • 5.3. U.S. Aseptic Connectors and Welders Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 5.3.1. Upstream Bioprocessing
      • 5.3.1.1. Upstream Bioprocessing market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.1.2. Media Preparation
      • 5.3.1.3. Media Preparation market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.1.4. Cell Inoculation
      • 5.3.1.5. Cell Inoculation market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.1.6. Cell Expansion
      • 5.3.1.7. Cell Expansion market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.1.8. Sampling
      • 5.3.1.9. Sampling market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.3.2. Other applications
      • 5.3.2.1. Other applications market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.3.3. Downstream Bioprocessing
      • 5.3.3.1. Downstream Bioprocessing market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.2. Purification
      • 5.3.3.3. Purification market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.4. Filtration
      • 5.3.3.5. Filtration market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.6. Sampling
      • 5.3.3.7. Sampling market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.8. Fluid Transfer
      • 5.3.3.9. Fluid Transfer market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.10. Other Applications
      • 5.3.3.11. Other Applications market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.3.4. Harvest & Fill-finish Operations
      • 5.3.4.1. Harvest & Fill-finish Operations market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.2. Product Collection
      • 5.3.4.3. Product Collection market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.4. Filtration
      • 5.3.4.5. Filtration market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.6. Product Filling
      • 5.3.4.7. Product Filling market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.8. Sampling
      • 5.3.4.9. Sampling market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.10. QC Testing
      • 5.3.4.11. QC Testing market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. U.S. Aseptic Connectors and Welders Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. U.S. Aseptic Connectors and Welders Market End Use Movement Analysis
  • 6.3. U.S. Aseptic Connectors and Welders Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Pharmaceutical Companies
    • 6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. OEMs
    • 6.5.1. OEMs market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. CROs & CMOs
    • 6.6.1. CROs & CMOs market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Academic & Research Institutes
    • 6.7.1. Academic & research institutes market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Danaher Corporation (Cytiva)
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Saint-Gobain
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Dover Corporation (Colder Products Company)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Liquidyne Process Technologies, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. MGA Technologies
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.4. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Watson-Marlow Fluid Technology Solutions
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Terumo BCT, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. LePure Biotech LLC
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 U.S. Aseptic connectors and welders Market, By product, 2021 - 2033 (USD Million)
  • Table 5 U.S. Aseptic connectors and welders Market, By application, 2021 - 2033 (USD Million)
  • Table 6 U.S. Aseptic connectors and welders Market, By end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Aseptic connectors and welderss market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Aseptic connectors & welders market: Product outlook key takeaways
  • Fig. 13 Aseptic connectors & welders market: Product movement analysis
  • Fig. 14 U.S. aseptic connectors market, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. aseptic welders market, 2021 - 2033 (USD Million)
  • Fig. 16 Aseptic connectors & welders market: Application outlook and key takeaways
  • Fig. 17 Aseptic connectors & welders market: Application movement analysis
  • Fig. 18 U.S. upstream bioprocessing market, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. downstream bioprocessing market, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. harvest & fill-finish operations market, 2021 - 2033 (USD Million)
  • Fig. 21 Aseptic connectors & welders market: End use outlook and key takeaways
  • Fig. 22 Aseptic connectors & welders market: End use movement analysis
  • Fig. 23 U.S. biopharmaceutical & pharmaceutical companies market, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. OEMs market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. CROs & CMOs market, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. academic & research institutes market, 2021 - 2033 (USD Million)